Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer

• NARITA Shintaro

  Department of Urology, Akita University School of Medicine

• TSUCHIYA Norihiko

  Department of Urology, Akita University School of Medicine

• YUASA Takeshi

  Department of Medical Oncology and Genitourinary Oncology, Cancer Institute Hospital

• MAITA Shinya

  Department of Urology, Akita University School of Medicine

• OBARA Takashi

  Department of Urology, Akita University School of Medicine

• NUMAKURA Kazuyuki

  Department of Urology, Akita University School of Medicine

• TSURUTA Hiroshi

  Department of Urology, Akita University School of Medicine

• SAITO Mitsuru

  Department of Urology, Akita University School of Medicine

• INOUE Takamitsu

  Department of Urology, Akita University School of Medicine

• HORIKAWA Yohei

  Department of Urology, Akita University School of Medicine

• SATOH Shigeru

  Department of Urology, Akita University School of Medicine

• HABUCHI Tomonori

  Department of Urology, Akita University School of Medicine

Journal

• International journal of clinical oncology

  International journal of clinical oncology 17 (3), 204-211, 2012-06-01

Keywords

• Chemotherapy
• Prostate cancer
• Single nucleotide polymorphism
• Docetaxel

Details

• CRID: 1573668925543530752
• NII Article ID: 10030951423
• NII Book ID: AA11086579
• ISSN: 13419625
• Web Site: https://search.jamas.or.jp/link/ui/2013201294
• Text Lang: en
• Data Source:
  • CiNii Articles